![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61P 17/14 | (2018.01) |
C07C 255/60 | (2006.01) | ||
A61K 31/277 | (2006.01) | ||
A61P 1/18 | (2018.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
C07C 255/60 | (2013.01) | ||
A61P 19/00 | (2018.01) | ||
A61P 17/10 | (2018.01) | ||
A61P 5/24 | (2018.01) | ||
A61P 21/00 | (2018.01) | ||
A61P 13/00 | (2018.01) | ||
A61P 13/08 | (2018.01) | ||
A61P 17/08 | (2018.01) | ||
A61P 21/02 | (2018.01) | ||
A61P 5/28 | (2018.01) | ||
A61P 1/16 | (2018.01) | ||
A61P 11/00 | (2018.01) | ||
A61P 35/02 | (2018.01) | ||
A61P 43/00 | (2018.01) | ||
A61P 15/00 | (2018.01) | ||
A61P 1/04 | (2018.01) | ||
A61P 17/00 | (2018.01) | ||
A61K 31/277 | (2013.01) | ||
A61P 13/12 | (2018.01) | ||
A61P 25/00 | (2018.01) | ||
C07B2200/07 | (2013.01) |
(11) | Patento numeris | 3285757 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16783846.5 |
Europos patento paraiškos padavimo data | 2016-04-21 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-02-28 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-22 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2016/028623 |
Data | 2016-04-21 |
(87) | Numeris | WO 2016/172330 |
Data | 2016-10-27 |
(30) | Numeris | Data | Šalis |
201562150768 P | 2015-04-21 | US | |
201562220094 P | 2015-09-17 | US |
(72) |
NARAYANAN, Ramesh , US
MILLER, Duane D. , US
PONNUSAMY, Thamarai , KR
HWANG, Dong-Jin , US
DUKE, Charles B. , US
COSS, Christopher C. , US
JONES, Amanda , US
DALTON, James T. , US
|
(73) |
Oncternal Therapeutics, Inc. ,
12230 El Camino Real, Suite 300, San Diego, CA 92130,
US
University of Tennessee Research Foundation , 211 Conference Center Building 600 Henley Street, Knoxville, TN 37996, US |
(54) | SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF |
SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF |